SEARLE's CALAN 1990 SALES APPROACH $ 470 MIL. DESPITE COMPETITION IN CALCIUM ANTAGONIST MARKET; DICLOFENAC/MISOPROSTOL COMBO NDA TARGETED FOR 1991